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Abstract
Background/objectives: In addition to weight-loss, healthy dietary patterns and lower sodium intakes can help
reduce blood pressure (BP), but individualised dietary advice may be necessary to achieve these effects. This
study aimed to examine the impact of individualised dietary advice on BP in the intensive phase of a weight-
loss trial. Subjects/methods: Secondary analysis of baseline and 3-month data from the HealthTrack
randomised controlled trial (n = 211). Participants were randomly assigned to one of three dietary advice
groups: general advice (control), individualised advice (intervention group, I), or intervention group
supplemented with 30 g walnuts/day (IW). Resting BP and 24-h urine sodium and potassium were measured.
Dietary intake was evaluated through diet history interviews. Results: Unadjusted SBP reduced significantly in
all groups (IW and I groups P < 0.001; control group P = 0.002) and DBP in IW and I groups (P < 0.001).
Compared to controls, the reductions in BP were 3-4 mmHg greater in the I and IW groups, but this only
reached significance for DBP in the I group (−3.3 mmHg; P = 0.041). After controlling for age, sex,
medication, weight-loss, physical activity and smoking, only the IW group showed a significant association
between SBP reduction and increased urinary potassium (β = −0.101, P = 0.044), decreased
sodium:potassium ratio (β = 2.446, P = 0.037) and increased consumption of seed and nut products and
dishes (β = −0.108, P = 0.034). Conclusions: Dietary patterns with distinctive foods and lower
sodium:potassium ratios may enhance the effects of weight-loss on BP. The patterns were best achieved with
individualised dietary advice and food supplements.
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Abstract  23 
Background/Objective: In addition to weight-loss, healthy dietary patterns and lower sodium 24 
intakes can help reduce blood pressure (BP), but individualised dietary advice may be 25 
necessary to achieve these effects. This study aimed to examine the impact of individualised 26 
dietary advice on BP in the intensive phase of a weight-loss trial.  27 
Subjects/Methods: Secondary analysis of baseline and 3-months data from the HealthTrack 28 
randomized controlled trial (n=211). Participants were randomly assigned to one of 3 dietary 29 
advice groups; general advice (control), individualised advice (intervention group, I), or 30 
intervention group supplemented with 30 grams walnuts/day (IW). Resting BP and 24-h urine 31 
sodium and potassium were measured. Dietary intake was evaluated through diet history 32 
interviews.  33 
Results: Unadjusted SBP reduced significantly in all groups (IW and I groups P<0.001; 34 
control group P=0.002) and DBP in IW and I groups (P<0.001). Compared to controls, the 35 
reductions in BP were 3-4 mmHg greater in the I and IW groups, but this only reached 36 
significance for DBP in the I group (-3.3 mmHg; P=0.041). After controlling for age, sex, 37 
medication, weight-loss, physical activity and smoking, only the IW group showed a 38 
significant association between SBP reduction and increased urinary potassium (β=-0.101, 39 
P=0.044), decreased sodium:potassium ratio (β=2.446, P=0.037) and increased consumption of 40 
seed and nut products and dishes (β=-0.108, P=0.034).  41 
Conclusions: Dietary patterns with distinctive foods and lower sodium:potassium ratios may 42 
enhance the effects of weight-loss on BP. The patterns were best achieved with individualised 43 
dietary advice and food supplements. 44 
Keywords: blood pressure, dietary patterns, obese, potassium, sodium, walnuts, seafood 45 
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INTRODUCTION 46 
Hypertension or high blood pressure (BP) is a major risk factor for cardiovascular disease and 47 
the leading risk factor for total burden of disease and mortality worldwide.1 Lowering systolic 48 
BP (SBP) by 10 mmHg or diastolic BP (DBP) by 5 mmHg through the use of BP lowering 49 
medication has been shown to reduce the incidence of coronary heart disease events and stroke 50 
by 25% and 30% respectively.2 51 
Different lifestyle approaches have been recommended to lower BP. These include weight loss, 52 
regular physical activity, reducing dietary sodium intake and consuming a healthy diet.3 53 
Previously, dietary trials for BP-lowering have primarily focused on interventions that result in 54 
reductions in sodium intake, either with or without a concomitant increase in potassium intake. 55 
A systematic review of these trials shows that reducing dietary salt to 4.4 g/day (1716 mg 56 
sodium/day) leads to an estimated  reduction of 5.0 mmHg and 3.0 mmHg in SBP and DBP, 57 
respectively, in hypertensive subjects and 2.0 mmHg and 1.0 mmHg, respectively, in 58 
normotensive subjects.4 On the other hand, a meta-regression has shown an increase in 59 
potassium intake by 44 mmol/day (1716 mg/day) to be associated with a reduction of 2.4 60 
mmHg and 1.6 mmHg in SBP and DBP, respectively.5 However, the urinary sodium-to-61 
potassium (Na:K) ratio may be more strongly associated with BP than urinary sodium or 62 
potassium alone,6 and may be more indicative of total diet.  63 
Given that weight loss itself helps to reduce BP,7  adding knowledge of healthful food patterns 64 
to that of energy restriction may be beneficial in managing obesity and its related disorders 65 
such as hypertension. The relationship between obesity and hypertension is well established.8 66 
Patients with higher body mass index (BMI) have an increased risk of hospitalisations due to a 67 
wide range of cardiovascular diseases in which hypertension may also be implicated.9 As a 68 
result, weight loss is recommended as a strategy to lower BP in overweight and obese 69 
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individuals.3 An average of 5 kg weight loss resulted in BP reduction of 4.4 mmHg and 3.6 70 
mmHg in SBP and DBP respectively in a meta-analysis of 25 randomized controlled trials.7  71 
While weight loss is dependent on total food intake, investigations into the effects of single 72 
foods on BP have been conducted through randomized clinical trials and observational studies. 73 
These studies have focused on fruit and vegetables, meat, nuts, dairy foods, tea, and coffee.10-15 74 
Research that focuses on individual nutrients or single foods may not consider the complexity 75 
of the interdependence between nutrients and foods and their relationship with disease 76 
outcomes.16 In nutritional epidemiology, research on dietary patterns may present a broader 77 
view of the impact of nutrient and food intakes and enable a better understanding of the 78 
association between diet and chronic disease risk.17 Dietary patterns associated with BP include 79 
the Dietary Approaches to Stop Hypertension (DASH) diet,18 the Mediterranean diet19 and the 80 
Nordic diet.20 Given that improved dietary choices is a goal of dietary advice in practice, the 81 
aim of this study was to examine the impact of individualised dietary advice, on BP during a 82 
weight loss trial. 83 
SUBJECTS AND METHODS  84 
The current study is a secondary analysis using baseline and 3 month data from the 12-month 85 
HealthTrack randomized controlled trial, commencing in May 2014 and investigating whether 86 
a novel lifestyle intervention is more effective than usual care in achieving weight loss in 87 
overweight/obese adults. Participants were randomized to one of three groups: intervention [(I) 88 
(interdisciplinary intervention with individualised dietary advice], intervention + walnut [(IW) 89 
(interdisciplinary intervention with individualised dietary advice plus a supplement of 30 90 
grams of walnuts per day], or control [(C) (usual care]. Randomisation was performed by an 91 
investigator unrelated to the study using computer generated randomisation sequence. 92 
Participants were blinded to their randomised group. Dietary advice in both intervention groups 93 
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was provided in an individualised manner according to the targeted requirements and usual 94 
food habits of the participants. A number of food choices were prescribed from the food groups 95 
defined in the Australian Guide to Healthy Eating.21 This Guide was also used for the controls 96 
but advice was given in a general manner. In the IW group, walnut supplementation was 97 
integrated into diets so as not to provide extra energy but to increase the specificity of the 98 
intervention to consume healthy food. The control group received general advice on food 99 
choices that enabled them to adjust their usual food patterns to the dietary guidelines.21 The 100 
HealthTrack study was registered with the Australian and New Zealand Clinical Trial Registry 101 
(ANZCTRN 12614000581662) and was approved by the University of Wollongong/Illawarra 102 
Shoalhaven Local Health District Human Research Ethics Committee (HE13/189) including 103 
the current analysis. All participants provided their informed written consent before 104 
participating in the study. For the analysis reported here, the outcomes of interest were SBP 105 
and DBP. 106 
Study context: The HealthTrack Trial 107 
The HealthTrack study was conducted in the Illawarra, a major coastal region 70 km south of 108 
Sydney, Australia, with a detailed study protocol and primary results reported elsewhere.22,23 In 109 
brief, adults aged between 25 and 54 years were recruited via advertisements in local media 110 
(Figure 1). Participants were included if they had a BMI of 25-40 kg/m2 and were permanent 111 
residents of the Illawarra region. Participants were excluded if they did not have a good 112 
command of English language, had a serious medical condition that could limit their 113 
participation, immunodeficiency, reported regular alcohol intake of more than 50 g of alcohol 114 
per day, illegal use of drugs, or other major impediments to taking part in some components of 115 
the study.  116 
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SBP and DBP were measured in the supine position using an automatic BP monitor (OMRON 117 
BP-203RPE III, OMRON Healthcare Co. Ltd, Kyoto, Japan) and using appropriately sized BP 118 
cuffs for obese participants. Participants rested for 5 minutes after which a test BP reading was 119 
conducted. After 10 seconds, a confirmatory reading was recorded. All BP measurements were 120 
performed by trained health practitioners using standard techniques.  121 
For estimation of dietary sodium and potassium intake, urinary sodium and potassium 122 
excretion were used as biomarkers since they are considered the gold standard.24 It has also 123 
been shown that individuals with higher BMI usually under-report dietary sodium and over-124 
report dietary potassium intake.25 Participants were instructed to collect 24-h urine in the 125 
provided standard plastic containers. One 24-h urine collection was made at baseline and at 3 126 
months. After voiding the initial urine sample of the day, participants were requested to record 127 
the time and then collect all further urine samples for the subsequent 24 hours, ending at about 128 
the same time the following day. The collected sample was then taken to Southern IML 129 
Pathology whereby total urine volume was determined, and subsequently stored at 2-8 degrees 130 
centigrade. Indirect ion-specific electrodes were used to determine sodium and potassium 131 
concentrations whilst the creatinine concentration was determined using the Jaffe reaction 132 
colorimetric method.26 Samples were considered to be incomplete if their total volume was less 133 
than 500 mL (n = 1 at baseline, n = 1 at 3 months) and/or creatinine concentration levels were 134 
below 5.0 mmol/d (n = 1 at baseline) and therefore excluded from the present analysis.27  135 
Dietary intake was assessed through self-reported diet history interviews conducted by 136 
Accredited Practising Dietitians. Participants described their usual diet including types and 137 
amounts of food and drinks consumed using a validated protocol.28 Dietary data was entered 138 
into the FoodWorks nutrient analysis software program (Xyris software, FoodWorks. 2012: 139 
Brisbane, Australia). Dietary data was originally analysed using AUSNUT 2007 (ref. 29), 140 
which was the most recent survey-specific food composition database available when the study 141 
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began. Due to the subsequent release of AUSNUT 2011-2013 (ref. 30), dietary data was 142 
categorized as per the food groups in AUSNUT 2011-2013. In order to convert AUSNUT 2007 143 
foods to AUSNUT 2011-2013 equivalents, a matching file was created to using a systematic 144 
process which has been reported elsewhere.31 Specifically, intakes of the AUSNUT 2011-13 145 
major food groups seed and nut products and dishes, fruit products and dishes, and seafood 146 
products and dishes were determined. These food groups were selected as they were 147 
significantly associated with BP in a previous baseline analysis in this sample.32 148 
Physical activity was assessed through the International Physical Activity Questionnaire via the 149 
questionnaire’s short questions.33 Trained health practitioners conducted anthropometric 150 
measurements. Weight and percent body fat via bioelectrical impedance were measured on 151 
digital scales [Tanita scales, UM0703581(1), Tanita Corporation, Tokyo, Japan] with subjects 152 
wearing light indoor clothing and no shoes. Weight was recorded to the nearest 0.1 kg while 153 
percent body fat was recorded to the nearest 0.1%. Height was measured and recorded to the 154 
closest millimetre in accordance with established anthropometric protocols34 using a wall-155 
mounted stadiometer. The widest part of hip and narrowest waist circumference were measured 156 
to the nearest centimetre according to standard protocols.34 BMI was computed as weight (kg) 157 
divided by the height (m) squared. 158 
Statistical analysis  159 
Power calculations to determine the sample size were conducted using SAS PROC POWER 160 
whereby 120 participants per group were considered adequate, in order to detect a minimum of 161 
2.7 kg weight loss difference between groups which was the primary outcome. In this 162 
secondary analysis, baseline characteristics were presented as means and standard deviation for 163 
normally distributed data and median and interquartile range for data that was not normally 164 
distributed. To assess differences between study groups at baseline, one-way analysis of 165 
variance was conducted for normally distributed data while Kruskal-Wallis H test was 166 
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conducted for data that was not normally distributed. A chi square test was performed to 167 
compare difference in the proportion of participants with hypertension (participants were 168 
categorised as hypertensive if BP was ≥140/90 mmHg and/or taking antihypertensives) 169 
between study groups. To determine between-intervention differences in the change in weight, 170 
BP and urinary excretion, the one-way analysis of variance was used. To determine the 171 
difference between baseline and 3 months in each study group in weight, BP and urinary 172 
excretion, paired-samples T-test was used while the Wilcoxon signed-rank test was used to 173 
assess differences in the intake of key food groups (seed and nut products and dishes, fruit 174 
products and dishes, and seafood products and dishes). The one-way analysis of variance or 175 
Kruskal-Wallis H test was used to determine the difference between groups at each time point, 176 
and significant results were explored via post-hoc Tukey, Games-Howell test or Mann Whitney 177 
U tests with Bonferroni adjustment. We also repeated these analyses after excluding 178 
participants who were taking diuretics at baseline and/ or 3 months, as diuretics have been 179 
shown to increase sodium and potassium excretion.35 Multiple linear regression was performed 180 
to assess the association between change in BP from baseline and (1) change in urinary 181 
excretion and (2) consumption of key food groups, while controlling for age, sex, BP 182 
medication, weight loss, change in physical activity, and smoking. All analyses were 183 
performed in accordance with an as-treated analysis approach. Statistical analysis was 184 
performed using the Statistical Package for the Social Sciences (IBM Corp., SPSS for 185 
Windows Version 21, Armonk, New York, USA). Significance level was considered at P value 186 
<0.05.  187 
RESULTS 188 
Baseline characteristics 189 
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Participants (n=377) were randomized to one of the 3 groups; intervention + walnut (IW), 190 
intervention (I) or control (C). For this secondary analysis, complete BP, urinary excretion data 191 
and dietary intake data at baseline and 3 months was available from 211 participants (60 men 192 
and 151 women). Table 1 shows the baseline characteristics of the 3 groups.  193 
Change from baseline to 3 months 194 
Weight reduced significantly in all the three groups from baseline to 3 months (P <0.001 in all 195 
groups). Unadjusted for weight loss, SBP reduced significantly in all groups (IW, I: P < 0.001; 196 
C: P = 0.002) but DBP was only significantly reduced in the IW and I groups (P < 0.001) 197 
(Figure 2 and Table 2). Compared to controls, the reductions were greater in the IW group 198 
(SBP -3.7 mmHg, P = 0.06; DBP -2.8 mmHg, P = 0.057) and the I group (SBP -3.7 mmHg, P 199 
= 0.095; DBP -3.3 mmHg, P = 0.041). From a biomarker perspective, compared to the I group, 200 
the IW group showed greater reductions in urinary sodium (P = 0.007) and urinary Na:K ratio 201 
(P = 0.012), and the C group showed greater reductions in urinary sodium (P = 0.018) (Table 202 
3). From a food perspective, the IW group consumed greater amounts of seed and nut products 203 
and dishes compared to the I group and C group at 3 months (P < 0.001 and = 0.024 204 
respectively) and increased their intakes of these foods more (P < 0.001 and < 0.001 205 
respectively) across the intervention period. Both the IW and I groups also increased their 206 
intakes of fruit products and dishes during this time (P < 0.001 and= 0.005 respectively). 207 
Results were similar when participants on diuretics were excluded from the analysis (data not 208 
shown). 209 
Using multiple linear regression and controlling for age, sex, BP medication, weight loss, 210 
change in physical activity and smoking, only the IW group showed a significant association 211 
between the reduction in SBP and the increase in urinary potassium (β=-0.101, 95% CI:-212 
0.199,-0.003; P=0.044) and decrease in urinary Na:K ratio (β=2.446, 95% CI:0.152,4.740; 213 
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P=0.037) (Table 4). The control group did show an association between reduced urinary 214 
sodium and reduced DBP (P=0.028).  From a food perspective, the IW group also showed a 215 
significant association between reduction in SBP and an increase in the consumption of seed 216 
and nut products and dishes, and between a reduction in DBP and increased intake of seafood 217 
products and dishes. The results did not change after excluding participants who were taking 218 
diuretics at baseline and 3 months (data not shown).  219 
DISCUSSION 220 
This secondary analysis of data from a weight loss trial provided further insights into the 221 
impact of changes in dietary patterns, foods and nutrients on BP. The setting which tested 222 
individualised versus general dietary advice enabled this to occur.  Dietary patterns,18 key 223 
foods such as nuts36 and dietary levels of nutrients such as sodium4 and potassium5 can all 224 
affect BP, but these effects are also inter-related.37 The present analysis showed that 225 
individualised dietary advice, strengthened by a daily supplement of a heathy food, 30 g 226 
walnuts, resulted in greater decrease in urinary Na:K ratio, a parameter associated with lower 227 
BP.6 After adjusting for weight loss, we found the decrease in Na:K ratio and concomitant 228 
increase in intakes of the “nuts and seeds” and “seafood” food categories were significantly 229 
associated with BP reduction, confirming the effect of diet composition.  230 
The significantly greater reduction in Na:K ratio in the IW group was indicative of the dietary 231 
pattern achieved. Diets with a lower Na:K ratio have been negatively associated with 232 
hypertension in epidemiological studies38 and have been found to reduce BP in randomized 233 
controlled trials.39 Sodium and potassium play an interdependent role in affecting BP, whereby 234 
consumption of excessive sodium and insufficient potassium cause the vascular smooth muscle 235 
cell to contract and as a result lead to an increase in the peripheral vascular resistance which 236 
increases BP.40  237 
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The results of the current study build on our earlier analysis that identified an inverse 238 
association between BP and a dietary pattern that was rich in “nuts, seeds, fruit and fish” and 239 
BP.32 In addition, we found significant inverse associations between SBP and dietary patterns 240 
characterized by fruit and nuts, and between DBP and dietary patterns characterized by seafood 241 
in analyses of food-based dietary trials previously conducted.41 Other randomized controlled 242 
trials show have reported beneficial effects of walnut consumption on BP. In a 2-year study 243 
investigating the effect of a Mediterranean-style diet on endothelial function and inflammation 244 
markers in 180 patients with metabolic syndrome, a Mediterranean-style diet that included 245 
consumption of 25-50 g of walnuts per day significantly reduced SBP by 3 mmHg and DBP by 246 
2 mmHg compared to a control prudent diet.42 Likewise, in the PREDIMED study, the group 247 
following a Mediterranean diet which contained a daily supplement of 30 g mixed nuts 248 
including 15 g of walnuts showed greater reductions in ambulatory SBP and DBP (-2.4 mmHg 249 
and -1.0 mmHg respectively) after one year compared to the control diet.43 In a recent meta-250 
analysis of 21 randomized controlled trials, total nut consumption was shown to lower SBP by 251 
1.29 mmHg in participants without type 2 diabetes.36 Nuts contain high amounts of mono- and 252 
polyunsaturated fats, magnesium, potassium and fibre and are low in sodium and saturated fats 253 
and thus may elicit a BP lowering response.44 Consumption of nuts may also be associated with 254 
improved diet quality45 which in turn may lead to adoption of healthier dietary patterns. 255 
In this study, we also found the IW group showed an association between increased seafood 256 
consumption and decreased DBP. The effect of fish consumption on BP has been assessed in 257 
previous studies. For example, moderate consumption of fatty fish (150 g salmon, three times 258 
per week) led to greater reductions in DBP in an 8 week weight-loss study compared to lean 259 
fish, fish oil capsules or placebo capsules.46 While various studies have shown a BP lowering 260 
effect through supplementation with omega-3 polyunsaturated fatty acids,47 conclusive 261 
evidence on the effect of dietary fish intake on BP is lacking. This is possibly due to other 262 
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factors that may attenuate the protective effects such as the method of preparation, 263 
consumption of salted fish or presence of other contaminants such as mercury and pesticides.48  264 
Compared to individual foods, however, dietary pattern analysis may better demonstrate diet-265 
BP relationships since foods are not consumed in isolation but as part of a total diet. In 266 
addition, the concept of food synergy proposes that investigation of patterns of food 267 
consumption may be more informative than focussing on individual nutrients or single foods.49 268 
Our study has demonstrated that under weight-loss conditions, a dietary pattern with an 269 
increase in nuts, seeds and seafood was associated with reductions in BP. Further 270 
investigations are warranted on the effect of change in dietary patterns on change in BP 271 
especially in different cultural contexts and cuisines.  272 
One of the limitations of this analysis is that as a secondary analysis of a randomized controlled 273 
study testing the effects of forms of intervention on weight loss, there is a likelihood the 274 
analysis would be underpowered, particularly in relation to the analysis of changes in dietary 275 
patterns which carry a high degree of variability. However, as under-reporting of dietary 276 
sodium and over-reporting of dietary potassium occurs especially in individuals with higher 277 
BMI,25 a strength of the study was the assessment of sodium and potassium intake by the gold 278 
standard of 24-h urine excretion,24 with completeness of urine samples being determined by the 279 
use of urinary creatinine concentrations. Despite this, it is acknowledged that repeated 24-h 280 
urinary collections would have provided greater accuracy due to the well-known large day-to-281 
day intra-individual variability of sodium and potassium intake.50  282 
Our analysis observed significant reductions in SBP that were associated with increased intake 283 
of seeds and nuts and reduced Na:K  excretion, while  reductions in DBP were associated with 284 
increased intake of seafood. Identification of a dietary pattern that includes these foods and 285 
leads to a low Na:K ratio could be helpful in the development of food based dietary 286 
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recommendations in clinical practice that not only address weight loss but also BP. In the 287 
context of this trial, the impact of individualised dietary advice (and the inclusion of a relevant 288 
food supplement) helped to achieve a healthy dietary pattern and expose effects. 289 
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FIGURE LEGENDS  473 
Figure 1 474 
Participant flow in the HealthTrack study and available data for the current analysis. Adapted 475 
from Tapsell L.C., Lonergan M., Martin A., Batterham M.J., and Neale E.P., Interdisciplinary 476 
lifestyle intervention for weight management in a community population (HealthTrack study): 477 
study design and baseline sample characteristics. Contemporary Clinical Trials, 2015(45): p. 478 
394-403. 479 
Figure 2 480 
Change in systolic and diastolic blood pressure in each group from baseline to 3 months and 481 
between intervention groups and control group. C, control (usual care); DBP, diastolic blood 482 
pressure; I, interdisciplinary intervention with individualised dietary advice; IW, 483 
interdisciplinary intervention with individualised dietary advice plus a supplement of 30 grams 484 
of walnuts per day; SBP, systolic blood pressure; asterisks (*) indicate significant change at P 485 
< 0.05; Error bars indicate standard error of the mean. 486 
 487 
 488 
 489 
 490 
 491 
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Table 1. Baseline characteristics of the 211 participants with complete data on blood pressure, urinary 
sodium and potassium and dietary intake in the HealthTrack study (n=211)1 
Characteristic  IW (n=82) I (n=62) C (n=67) P value for 
group 
difference2 
     
Age, years 43.2 (8.7) 45.2 (7.1) 45.1 (7.2) 0.242 
Height, m 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 0.397 
Weight, kg 90.0 (14.6) 93.0 (16.1) 89.6 (15.4) 0.4 
BMI, kg/m2 32.0 (4.1) 32.6 (4.4) 32.2 (4.2) 0.784 
Waist 
circumference, 
cm 
102.4 (11.4) 104.7 (11.8) 103.7 (13.3) 0.57 
Hypertensives, % 
(n)3 
31.7 (26) 32.3 (20) 26.9 (18) 0.755 
Dietary intake     
Median energy, 
kj/day (IQR) 
8671 (7309-10350) 8618 (7701-10981) 9486 (8066-11438) 0.165 
Median sodium, 
mg/day (IQR) 
2453 (1974-3037) 2260 (1682-3099) 2521 (2003-3065) 0.452 
Median 
potassium, 
mg/day (IQR) 
3694 (3027-4211) 3519 (3044-4452) 3849 (3191-4674) 0.123 
Median 
magnesium, 
mg/day (IQR) 
423 (329-542) 427 (331-522) 449 (349-570) 0.214 
Median calcium, 
mg/day (IQR) 
894 (663-1134) 985 (713-1234) 951 (731-1233) 0.334 
Urinary 
excretion4 
    
Volume, mL/day 2114 (962) 2048 (874) 2018 (838) 0.799 
Creatinine, 
mmol/day 
13.6 (4.4) 14.2 (4.1) 13.8 (4.7) 0.758 
Sodium, 
mmol/day 
149.7 (54.6) 138.2 (62.5) 151.0 (61.7) 0.448 
Median sodium, 
mmol/day (IQR) 
137 (108-191) 128 (97-170) 145 (99-181) 0.391 
Potassium, 
mmol/day 
75.5 (27.8) 77.9 (21.3) 84.5 (38.0) 0.276 
Median 
potassium, 
mmol/day (IQR) 
72 (54-89) 77 (63-91) 75 (59-98) 0.319 
Sodium-to-
potassium ratio 
2.1 (0.99)a 1.8 (0.57)b 2.0 (0.85)ab 0.024 
Median sodium-
to-potassium 
ratio (IQR) 
1.9 (1.4-2.7) 1.8 (1.3-2.1) 1.9 (1.4-2.1) 0.206 
1Values are expressed as means (standard deviation) unless otherwise stated; 2Group comparisons 
were made using analysis of variance for normally distributed data;  3Group comparisons were made 
using Chi square test;  4Group comparisons were made using Kruskal-Wallis H test for data that was 
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not normally distributed; C, control (usual care); I, interdisciplinary intervention with individualised 
dietary advice; IQR, interquartile range; IW, interdisciplinary intervention with individualised dietary 
advice plus a supplement of 30 grams of walnuts per day. 
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Table 2. Change in weight and blood pressure from baseline to 3 months in the HealthTrack study (n=211)1 
  IW (n=82) I (n=62) C (n=67) P value for 
group 
difference 
IW vs. C (95% CI) P value I vs. C 
(95% CI) 
P 
value 
Weight  
(Kg)  
Baseline  90.0 ± 14.6 93.0 ± 16.1 89.6 ± 15.4 0.394     
 3 months 87.2 ± 14.2 90.0 ± 16.1 88.2 ± 15.4 0.54     
 Change 
(95% CI) 
-2.8 (-3.6 to -
2.0)a 
-2.9 (-3.8 to -
2.1)a 
-1.4 (-1.9 to -
0.9)b 
0.007 -1.4 (-2.5 to -0.2) 0.021 -1.5 (-2.8 
to -0.3) 
0.013 
 P value for 
difference 
between 
baseline and 
3m 
<0.001 <0.001 <0.001      
Blood 
pressure 
Baseline  127.5 ± 16.6 127.5 ± 18.6 123.0 ± 13.0      
SBP 
(mmHg) 
3 months 120.5 ± 13.3 120.5 ± 15.6 119.7 ± 12.5      
 Change 
(95% CI) 
-7.0 (-9.5 to -4.6) -7.0 (-9.8 to -4.2) -3.3 (-5.4 to -1.2) 0.057 -3.7 (-7.5 to 0.1) 0.06 -3.7 (-7.9 
to 0.5) 
0.095 
 P value for 
difference 
between 
baseline and 
3m 
<0.001 <0.001 0.002      
 Baseline  74.2 ± 10.3 75.0 ± 12.5 72.6 ± 9.4      
DBP 
(mmHg) 
3 months 69.8 ± 9.3 70.1 ± 11.3 71.0 ± 9.0      
EJCN article March 2018 
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 Change 
(95% CI) 
-4.4 (-6.0 to -
2.7)ab 
-4.9 (-7.0 to -
2.8)b 
-1.6 (-3.3 to 0.2)a 0.027 -2.8 (-5.7 to 0.1) 0.057 -3.3 (-6.6 
to -0.1) 
0.041 
 P value for 
difference 
between 
baseline and 
3m 
<0.001 <0.001 0.076      
1Values are mean ± standard deviation unless otherwise stated; a,b,cGroups with different superscripts were significantly different after Bonferroni 
adjustment; change in blood pressure unadjusted for weight loss; C, control (usual care); DBP, diastolic blood pressure; I, interdisciplinary intervention with 
individualised dietary advice; IW, interdisciplinary intervention with individualised dietary advice plus a supplement of 30 grams of walnuts per day; SBP, 
systolic blood pressure. 
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Table 3. Change in 24-h urinary excretion and key food groups from baseline to 3 months in the HealthTrack study (n=211)1 
  IW (n=82) I (n=62) C (n=67) P value for 
group 
difference 
Urinary excretion      
Urinary sodium (mmol/d)  Baseline  149.7 (54.6) 138.2 (62.5) 151.0 (61.7) 0.448 
 3 months 118.9 (55.1) 138.3 (56.7) 125.0 (62.3) 0.135 
 Change  -30.8 (62.2)a 0.1 (69.6)b -26.0 (80.8)ab 0.026 
 P value for difference 
between baseline and 
3m 
<0.001 0.991 0.011  
Urinary potassium (mmol/d)  Baseline  75.5 (27.8) 77.9 (21.3) 84.5 (38.0) 0.276 
 3 months 72.6 (29.3) 77.6 (24.9) 72.2 (22.8) 0.416 
 Change  -2.95 (26.5)ab -0.26 (21.9)a -12.3 (35.7)b 0.042 
 P value for difference 
between baseline and 
3m 
0.316 0.926 0.006  
Urinary Na:K ratio 
(mmol/mmol)  
Baseline  2.13 (0.99)a 1.77 (0.57)b 1.96 (0.85)ab 0.024 
 3 months 1.79 (0.79) 1.91 (0.84) 1.80 (0.78) 0.654 
 Change  -0.34 (1.06)a 0.14 (0.80)b -0.16 (1.06)ab 0.02 
 P value for difference 
between baseline and 
3m 
0.006 0.187 0.217  
Food groups       
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Seed and nut products and dishes 
(g/d), median (IQR) 
Baseline 13.4 (5.4-34.4) 16.2 (6.4-30.6) 18.2 (7.1-37.5) 0.56 
 3 months 30.0 (27.4-37.3)a 10.4 (4.2-19.1)b 20.4 (6.9-41.2)c <0.001 
 Change  20.4 (4.9 to 30)a -1.5 (-13.5 to 5.1)b -1.8 (-18.5 to 11.6)bc <0.001 
 P value for difference 
between baseline and 
3m 
<0.001 0.008 0.766  
Fruit products and dishes (g/d), 
median (IQR) 
Baseline  113.1 (57.7-224.7) 151.4 (81.0-258.8) 140.8 (69.9-231.6) 0.276 
 3 months 212.3 (146.7-270.9)ab 241.9 (149.6-301.4)a 160.9 (109.9-262.7)b 0.022 
 Change  62.5 (-10.8 to 169.1) 79.2 (-37.6 to 168.9) 37.0 (-51.6 to 107.2) 0.073 
 P value for difference 
between baseline and 
3m 
<0.001 0.005 0.096  
Seafood products and dishes 
(g/d), median (IQR) 
Baseline  35.0 (19.8-58.3) 35.4 (14.9-60.6) 32.9 (20.0-67.1) 0.957 
 3 months 35.1 (20.3-64.3) 45.4 (21.1-67.5) 40.1 (20.4-57.1) 0.404 
 Change  7.8 (-11.0 to 20.1) 2.9 (-15.8 to 29.6) 0.0 (-15.9 to 16.8) 0.641 
 P value for difference 
between baseline and 
3m 
0.224 0.31 0.716  
1Values are mean (standard deviation) unless otherwise stated; a,b,cGroups with different superscripts were significantly different after Bonferroni adjustment; 
C, control (usual care); I, interdisciplinary intervention with individualised dietary advice; IW, interdisciplinary intervention with individualised dietary 
advice plus a supplement of 30 grams of walnuts per day; Na:K. sodium-to-potassium ratio. 
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Table 4. Linear regression for association between change in blood pressure and change in urinary markers and key food groups in the HealthTrack study 
(n=211)1 
 IW (n=82)  I (n=62)  C (n=67)  
        
 B ± SE P value  B ± SE P value  B ± SE P value  
Change in SBP       
Change in urinary Na (mmol/d) 0.009 ± 0.021 0.687 0.010 ± 0.022 0.649 0.019 ± 0.013 0.154 
Change in urinary K (mmol/d) -0.101 ± 0.050 0.044 0.057 ± 0.074 0.445 0.022 ± 0.031 0.471 
Change in Na:K ratio 2.446 ± 1.171 0.037 -1.107 ± 1.976 0.575 0.442 ± 1.041 0.671 
Change in consumption of seed and nut products 
and dishes (g/d) 
-0.108 ± 0.051 0.034 -0.002 ± 0.061 0.975 -0.011 ± 0.021  0.608 
Change in consumption of fruit products and dishes 
(g/d) 
-0.002 ± 0.010 0.867 -0.007 ± 0.010 0.451 0.002 ± 0.006 0.785 
Change in consumption of seafood products and 
dishes (g/d) 
-0.072 ± 0.041 0.083 -0.056 ± 0.032 0.077 -0.011 ± 0.030 0.72 
Change in DBP       
Change in urinary Na (mmol/d) 0.007 ± 0.015 0.644 0.005 ± 0.017 0.751 0.024 ± 0.011 0.028 
Change in urinary K (mmol/d) -0.056 ± 0.034 0.103 0.070 ± 0.056 0.213 0.010 ± 0.025 0.697 
Change in Na:K ratio 1.500 ± 0.808 0.063 -1.141 ± 1.497 0.446 0.856 ± 0.851 0.315 
Change in seed and nut products and dishes (g/d) -0.046 ± 0.035 0.195 0.003 ± 0.047 0.946 -0.014 ± 0.017 0.925 
Change in fruit products and dishes (g/d) -0.004 ± 0.007 0.59 -0.003 ± 0.008 0.653 0.001 ± 0.005 0.672 
Change in seafood products and dishes (g/d) -0.063 ± 0.028 0.024 0.030 ± 0.025 0.231 -0.0002 ± 
0.024 
0.994 
1Controlling for age, sex, BP medication, weight loss, change in physical activity, smoking; C, control (usual care); DBP, diastolic blood pressure; I, 
interdisciplinary intervention with individualised dietary advice; IW, interdisciplinary intervention with individualised dietary advice plus a supplement of 30 
grams of walnuts per day; K, potassium; Na, sodium; Na:K. sodium-to-potassium ratio; SBP, systolic blood pressure. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
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